New Products: Biognosys, Phenomenex | GenomeWeb

Biognosys has launched its new BloodSpotDive 100 multiple-reaction monitoring mass spec panel for dried blood spot analysis.

According to the company, the panel allows for routine quantification of 100 blood proteins directly from DBS samples. It is available as a fee-for-service product out of Biognosys' laboratory or for transfer to any lab equipped with a triple quadrupole mass spec.


Phenomenex has launched its 30 mm Kinetex core-shell 5-micron column for pharmaceutical lab-scale purifications.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.